Search research articles
Contact Us
Filters
Showing results (111-120 of 199) with videos related to
Page
of 20
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 5, 2011
Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: impact of inactivation parameters and enzyme turnover
K Rowland Yeo, R L Walsky, M Jamei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 19, 2000
The 1'-hydroxylation of Rac-bufuralol by rat brain microsomes
T Coleman, E F Spellman, A Rostami-Hodjegan, et al.
Journal of Neuroimmunology
|
July 20, 2000
The suppressive effect of TGF-beta on IL-12-mediated immune modulation specific to a peptide Ac1-11 of myelin basic protein (MBP): a mechanism involved in inhibition of both IL-12 receptor beta1 and beta2
H Xu, G X Zhang, M Wysocka, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 27, 2002
Determination of midazolam and 1'-hydroxymidazolam by liquid chromatography-mass spectrometry in plasma of patients undergoing methadone maintenance treatment
M R Shiran, A Gregory, A Rostami-Hodjegan, et al.
Current Drug Metabolism
|
March 29, 2012
Physiologically-based pharmacokinetic (PBPK) models for assessing the kinetics of xenobiotics during pregnancy: achievements and shortcomings
G Lu, K Abduljalil, M Jamei, et al.
Clinical and Experimental Immunology
|
January 7, 2014
Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
T Kalantari, M H Karimi, B Ciric, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2013
A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction
A B Ke, S C Nallani, P Zhao, et al.
Cellular Immunology
|
June 1, 1994
Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1
S K Gregorian, W P Lee, L S Beck, et al.
The American Journal of Physiology
|
May 12, 1998
Population-based modeling to demonstrate extrapancreatic effects of tolbutamide
A Rostami-Hodjegan, S R Peacey, E George, et al.
The Journal of Small Animal Practice
|
April 27, 2012
Severe dermatophytosis due to Trichophyton mentagrophytes var. interdigitale in flocks of green iguanas (Iguana iguana)
A R Khosravi, H Shokri, A Rostami, et al.
Page
of 20
Search research articles
Search
Showing results (111-120 of 199) with videos related to
Sort By:
Page
of 20
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
May 5, 2011
Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: impact of inactivation parameters and enzyme turnover
K Rowland Yeo, R L Walsky, M Jamei, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
August 19, 2000
The 1'-hydroxylation of Rac-bufuralol by rat brain microsomes
T Coleman, E F Spellman, A Rostami-Hodjegan, et al.
Journal of Neuroimmunology
|
July 20, 2000
The suppressive effect of TGF-beta on IL-12-mediated immune modulation specific to a peptide Ac1-11 of myelin basic protein (MBP): a mechanism involved in inhibition of both IL-12 receptor beta1 and beta2
H Xu, G X Zhang, M Wysocka, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 27, 2002
Determination of midazolam and 1'-hydroxymidazolam by liquid chromatography-mass spectrometry in plasma of patients undergoing methadone maintenance treatment
M R Shiran, A Gregory, A Rostami-Hodjegan, et al.
Current Drug Metabolism
|
March 29, 2012
Physiologically-based pharmacokinetic (PBPK) models for assessing the kinetics of xenobiotics during pregnancy: achievements and shortcomings
G Lu, K Abduljalil, M Jamei, et al.
Clinical and Experimental Immunology
|
January 7, 2014
Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells
T Kalantari, M H Karimi, B Ciric, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 10, 2013
A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction
A B Ke, S C Nallani, P Zhao, et al.
Cellular Immunology
|
June 1, 1994
Regulation of experimental autoimmune neuritis by transforming growth factor-beta 1
S K Gregorian, W P Lee, L S Beck, et al.
The American Journal of Physiology
|
May 12, 1998
Population-based modeling to demonstrate extrapancreatic effects of tolbutamide
A Rostami-Hodjegan, S R Peacey, E George, et al.
The Journal of Small Animal Practice
|
April 27, 2012
Severe dermatophytosis due to Trichophyton mentagrophytes var. interdigitale in flocks of green iguanas (Iguana iguana)
A R Khosravi, H Shokri, A Rostami, et al.
Page
of 20